• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Jul 10;ciaa963.
doi: 10.1093/cid/ciaa963. Online ahead of print.
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia


Yi-Min Dong[SUP] 1 [/SUP], Jia Sun[SUP] 2 3 [/SUP], Yi-Xin Li[SUP] 4 [/SUP], Qian Chen[SUP] 5 [/SUP], Qing-Quan Liu[SUP] 6 [/SUP], Zhou Sun[SUP] 7 [/SUP], Ran Pang[SUP] 8 [/SUP], Fei Chen[SUP] 9 [/SUP], Bing-Yang Xu[SUP] 10 [/SUP], Anne Manyande[SUP] 11 [/SUP], Taane G Clark[SUP] 12 [/SUP], Jin-Ping Li[SUP] 13 [/SUP], Ilkay Erdogan Orhan[SUP] 14 [/SUP], Yu-Ke Tian[SUP] 2 3 [/SUP], Tao Wang[SUP] 15 [/SUP], Wei Wu[SUP] 1 [/SUP], Da-Wei Ye[SUP] 16 [/SUP]



Affiliations

Abstract

Background: The outbreak of coronavirus disease (COVID-19) in 2019 has spread worldwide and continues to cause great threat to peoples' health as well as put pressure on the accessibility of medical systems. Early prediction of survival of hospitalized patients will help the clinical management of COVID-19, but such a prediction model which is reliable and valid is still lacking.
Methods: We retrospectively enrolled 628 confirmed cases of COVID-19 using positive RT-PCR tests for SARS-CoV-2 in Tongji Hospital in Wuhan, China. These patients were randomly grouped into a training cohort (60%) and a validation cohort (40%). In the training cohort, least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate Cox regression analysis were utilized to identify prognostic factors for in-hospital survival of patients with COVID-19. A nomogram based on the three variables was built for clinical use. Areas under the ROC curves (AUC), concordance index (C-index) and calibration curve were used to evaluate the efficiency of the nomogram in both the training and validation cohorts.
Results: Hypertension, higher neutrophil-to-lymphocyte ratio and increased NT-proBNP value were found to be significantly associated with poorer prognosis in hospitalized patients with COVID-19. The three predictors were further used to build a prediction nomogram. The C-index of the nomogram in the training and validation cohorts was 0.901 and 0.892, respectively. The AUC in the training cohort was 0.922 for 14- day and 0.919 for 21-day probability of in-hospital survival, while in the validation cohort was 0.922 and 0.881, respectively. Moreover, the calibration curve for 14- day and 21-day survival also showed high coherence between the predicted and actual probability of survival.
Conclusion: We managed to build a predictive model and constructed a nomogram for predicting in-hospital survival of patients with COVID-19. This model represents good performance and might be utilized clinically in the management of COVID-19.

Keywords: COVID-19; Coronavirus; nomogram; prediction; survival.
 
Back
Top Bottom